• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why T2 Biosystems Shares Are Trading Lower By Over 28%, Here Are 41 Stocks Moving In Wednesday's Mid-Day Session

    10/12/22 12:00:16 PM ET
    $ADMP
    $AGFY
    $AHG
    $APDN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $ADMP alert in real time by email

    Gainers

    • Code Chain New Continent Limited (NYSE:CCNC) shares jumped 74% to $0.2868 after declining around 14% on Tuesday.
    • FLJ Group Limited (NASDAQ:FLJ) gained 69% to $2.59.
    • Hempacco Co., Inc. (NASDAQ:HPCO) shares climbed 57.8% to $3.4550 after the company reported a 486% year-on-year jump in first-half FY22 revenue to about $2.8 million.
    • Pineapple Energy Inc.. (NASDAQ:PEGY) gained 43% to $7.15. The stock has been a momentum name for a few weeks now.
    • Happiness Development Group Limited (NASDAQ:HAPP) rose 36% to $3.31. Happiness Development Group shareholders approved a 1 for 20 reverse split of ordinary shares.
    • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) climbed 31.8% to $0.1929 after jumping over 16% on Tuesday. Adamis Pharmaceuticals recently announced a review of strategic alternatives.
    • Agrify Corporation (NASDAQ:AGFY) gained 28.4% to $0.6517 after climbing over 32% on Tuesday.
    • Applied DNA Sciences, Inc(NASDAQ:APDN) gained 28% to $2.60. Applied DNA Sciences recently received its largest single purchase order for LinearDNA™ valued above the mid-six-figures.
    • Gatos Silver, Inc. (NYSE:GATO) rose 14.9% to $2.9650. Gatos Silver reported a 59% year-over-year surge in Q3 silver production.
    • Cango Inc. (NYSE:CANG) rose 13.1% to $2.5550 after the company declared a special cash dividend of $0.50 per share.
    • El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) gained 12.7% to $10.26 after the company declared a special dividend of $1.50 per share and approved a 20 million share buyback program.
    • KnowBe4, Inc. (NASDAQ:KNBE) gained 12.6% to $24.32 after the company announced it will be acquired by Vista Equity Partners for $4.6 billion.
    • Siyata Mobile Inc. (NASDAQ:SYTA) jumped 12.4% to $0.1452. Siyata Mobile recently agreed to sell 15.8 million shares and 1.59 million pre-funded warrants to certain institutional investors in a private placement.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) surged 12.2% to $0.7519. On October 11, China SXT Pharmaceuticals received the funds from Mr. Xiao who previously agreed to purchase 1,625,798 shares of the company, par value $0.08/share at a per share purchase price of $1.35.
    • RLX Technology Inc. (NYSE:RLX) gained 11.5% to $1.11. RLX recently reported a second-quarter FY22 sales decline of 12% year-on-year to $333.50 million.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) rose 10.8% to $1.23.
    • Moderna, Inc. (NASDAQ:MRNA) gained 10% to $132.78. Moderna said Merck & Co had exercised an option to jointly develop and potentially sell personalized mRNA-based cancer vaccine. The FDA also authorized Moderna and Pfizer-BioNTech bivalent Covid-19 vaccines for use as a booster dose in younger age groups.
    • AMTD Digital Inc. (NYSE:HKD) rose 9.4% to $45.07 after jumping 35% on Tuesday.
    • AZZ Inc. (NYSE:AZZ) gained 8.8% to $33.09. AZZ, on Tuesday, reported worse-than-expected Q2 adjusted EPS results. The company said it will not issue full-year fiscal year 2023 guidance at this time.
    • ObsEva SA (NASDAQ:OBSV) rose 7.3% to $0.1698 after dropping 3% on Tuesday.


    Losers

    • FedNat Holding Company (NASDAQ:FNHC) fell 32.5% to $0.2291 after jumping 108% on Tuesday.
    • Kinnate Biopharma Inc. (NASDAQ:KNTE) shares dipped 30% to $7.75. Kinnate Biopharma late Tuesday said, 'Initial site activation was slower than expected due to COVID-19. This has resulted in a limited number of efficacy evaluable patients to-date in the relevant population at the predicted efficacious dose.'
    • T2 Biosystems, Inc. (NASDAQ:TTOO) dropped 28.5% to $0.0571 after the company cut FY22 sales guidance to below analyst estimates and announced a 1-for-50 reverse stock split.
    • Owens & Minor, Inc. (NYSE:OMI) fell 24.3% to $17.58 after the company lowered its F22 adjusted EPS guidance. The company named Alexander J. Bruni as EVP and CFO.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) fell 22% to $1.3155. The company said, for the quarter ended September 30, 2022, it expects to report total revenue of approximately $4.6 million.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) dipped 20.3% to $11.34.
    • Uxin Limited (NASDAQ:UXIN) fell 19.9% to $0.4878 after the company announced a 1-for-10 reverse ADS split.
    • Akso Health Group (NASDAQ:AHG) dropped 18% to $0.66.
    • Mercurity Fintech Holding Inc. (NASDAQ:MFH) declined 17.1% to $0.8701.
    • Nuwellis, Inc. (NASDAQ:NUWE) dropped 16% to $0.3530.
    • Cameco Corporation (NYSE:CCJ) fell 15.4% to $21.84 after the company announced a $650 million bought deal offering of common shares at a price of $21.95 per share.
    • Immunic, Inc. (NASDAQ:IMUX) shares fell 13.5% to $8.14 after jumping around 52% on Tuesday. Immunic recently announced $60 million oversubscribed private placement equity financing.
    • Koninklijke Philips N.V. (NYSE:PHG) shares fell 11.9% to $13.14. Philips said it expects third-quarter group sales to be approximately €4.3 billion with a comparable sales decline of approximately 5%. Due to the lower sales, Group Adjusted EBITA for the quarter is expected to be around €210 million or around 5% of sales.
    • Enviva Inc. (NYSE:EVA) dropped 11.8% to $52.00 after Blue Orca issued a bearish report on the stock.
    • Global Blue Group Holding AG (NYSE:GB) declined 10.3% to $3.81.
    • Doximity, Inc. (NYSE:DOCS) fell 10.3% to $26.30.
    • WeWork Inc. (NYSE:WE) dropped 9% to $2.2650.
    • CTI BioPharma Corp. (NASDAQ:CTIC) declined 8.8% to $4.6250.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) dropped 8.5% to $0.5064.
    • VOXX International Corporation (NASDAQ:VOXX) shares fell 8.5% to $6.61 after the company reported weaker-than-expected earnings results for its second quarter on Tuesday.
    • Peloton Interactive, Inc. (NASDAQ:PTON) dropped 7.3% to $8.14.
    Get the next $ADMP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADMP
    $AGFY
    $AHG
    $APDN

    CompanyDatePrice TargetRatingAnalyst
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Doximity Inc.
    $DOCS
    2/9/2026$34.00Hold → Buy
    Canaccord Genuity
    Doximity Inc.
    $DOCS
    2/6/2026$40.00Underweight → Neutral
    Analyst
    Peloton Interactive Inc.
    $PTON
    2/6/2026$8.00 → $6.00Market Perform
    Telsey Advisory Group
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    Doximity Inc.
    $DOCS
    1/20/2026$55.00Equal Weight → Overweight
    Wells Fargo
    Doximity Inc.
    $DOCS
    1/9/2026$59.00Outperform
    RBC Capital Mkts
    Doximity Inc.
    $DOCS
    1/8/2026Hold → Buy
    Truist
    More analyst ratings

    $ADMP
    $AGFY
    $AHG
    $APDN
    SEC Filings

    View All

    SEC Form SCHEDULE 13D filed by Immunic Inc.

    SCHEDULE 13D - IMMUNIC, INC. (0001280776) (Subject)

    2/20/26 6:59:39 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form PRE 14A filed by Immunic Inc.

    PRE 14A - IMMUNIC, INC. (0001280776) (Filer)

    2/20/26 5:00:26 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-8 filed by Moderna Inc.

    S-8 - Moderna, Inc. (0001682852) (Filer)

    2/20/26 4:03:07 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADMP
    $AGFY
    $AHG
    $APDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update

    – Top-Line Data from Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis Expected by Year-End 2026 –– Raised Proceeds of $200 Million in a Private Placement, with Potential for up to an Additional $200 Million –– Net Proceeds Expected to Fund Completion of Phase 3 ENSURE Trials in Relapsing Multiple Sclerosis, Initiation of Phase 3 Trial in Primary Progressive Multiple Sclerosis and Begin of Transition into a Commercial Organization –NEW YORK, Feb. 26, 2026  /PRNewswire/ -- Immunic, Inc. (NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced financial results

    2/26/26 6:30:00 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    El Pollo Loco Holdings, Inc. to Announce Fourth Quarter and Full Year 2025 Results on Thursday, March 12, 2026

    COSTA MESA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. ("El Pollo Loco") (NASDAQ:LOCO) today announced that it will host a conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, at 4:30 PM Eastern Time. Hosting the call will be Liz Williams, Chief Executive Officer, and Ira Fils, Chief Financial Officer. A press release with fourth quarter and full year 2025 financial results will be issued that same day, shortly after the market close. The conference call can be accessed live over the phone by dialing 201-493-6780. A replay will be available after the call and can be accessed by dialing 412-317-6671; the

    2/25/26 9:00:00 AM ET
    $LOCO
    Restaurants
    Consumer Discretionary

    El Pollo Loco Announces Protein Packed Menu, Reminding Everyone that Protein has Always Been their Specialty

    With 24 protein heavy hitters, all under $15, the menu delivers big flavor, great value, and plenty of ways to fuel up COSTA MESA, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- El Pollo Loco, the nation's leading fire-grilled chicken restaurant chain, today announced its Protein Packed Menu, a curated lineup of more than 20 protein-heavy existing menu items crafted to meet growing consumer demand for balanced, flavorful, and functional meals. Now available online, the Protein Packed Menu reimagines what "high protein" means in quick‑service dining. Centered on the brand's signature fire‑grilled chicken, the lineup spans burritos, salads, bowls, and more – with multiple items delivering over

    2/24/26 11:37:55 AM ET
    $LOCO
    Restaurants
    Consumer Discretionary

    $ADMP
    $AGFY
    $AHG
    $APDN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SYMJEPI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug SYMJEPI (SUPPL-12) with active ingredient EPINEPHRINE has changed to 'Approval' on 06/29/2021. Application Category: NDA, Application Number: 207534, Application Classification: Labeling

    6/30/21 5:11:48 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADMP
    $AGFY
    $AHG
    $APDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Peloton downgraded by Argus

    Argus downgraded Peloton from Buy to Hold

    2/10/26 7:17:53 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Doximity upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Doximity from Hold to Buy and set a new price target of $34.00

    2/9/26 6:58:22 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by Analyst with a new price target

    Analyst upgraded Doximity from Underweight to Neutral and set a new price target of $40.00

    2/6/26 8:05:27 AM ET
    $DOCS
    EDP Services
    Technology

    $ADMP
    $AGFY
    $AHG
    $APDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Hoge Stephen exercised 160,009 shares at a strike of $19.15 and sold $7,814,840 worth of shares (160,009 units at $48.84) (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    2/25/26 4:49:00 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Content Officer Cotter Jennifer Cunningham sold $681,672 worth of shares (154,497 units at $4.41), decreasing direct ownership by 61% to 100,269 units (SEC Form 4)

    4 - PELOTON INTERACTIVE, INC. (0001639825) (Issuer)

    2/24/26 6:55:21 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Chief Commercial Officer Sanders Dion C. sold $647,934 worth of shares (146,844 units at $4.41), closing all direct ownership in the company (SEC Form 4)

    4 - PELOTON INTERACTIVE, INC. (0001639825) (Issuer)

    2/24/26 6:54:30 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    $ADMP
    $AGFY
    $AHG
    $APDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Endeavor Blockchain, Llc bought $192,502 worth of shares (42,100 units at $4.57), decreasing direct ownership by 100% to 4,397 units (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/30/26 7:58:02 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    Large owner Endeavor Blockchain, Llc bought $290,400 worth of shares (60,000 units at $4.84), increasing direct ownership by 4% to 1,460,000 units (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/26/26 7:22:56 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    Large owner Endeavor Blockchain, Llc bought $4,388,681 worth of shares (801,279 units at $5.48) (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/22/26 5:47:16 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    $ADMP
    $AGFY
    $AHG
    $APDN
    Leadership Updates

    Live Leadership Updates

    View All

    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board. Dr. Nader brings more than 30 years of leadership experience across the biotechnology and pharmaceutical industry and currently serves as an Independent Director of Moderna, Inc. (NASDAQ:MRNA), a glo

    2/23/26 4:01:00 PM ET
    $MRNA
    $TECX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Greenwave Announces Appointment of Chelsea Pullano as Chief Financial Officer

    Chesapeake, VA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (NASDAQ:GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that the board of directors ("Board") of the Company appointed Chelsea Pullano as Chief Financial Officer of the Company, effective February 5, 2026. Ms. Pullano's appointment is in connection with the Company's entry into the scope of work agreement with MACK Financial Solutions, LLC ("MACK"), dated January 2, 2026, pursuant to which MACK agreed to provide professional services to the Company, including oversight of all bookkeeping, financial reporting and SEC r

    2/10/26 4:15:00 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    Philips proposes to re-appoint CEO Roy Jakobs

    February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board's recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. "Roy Jakobs has demonstrated clear leadership, strong execution

    2/10/26 12:55:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $ADMP
    $AGFY
    $AHG
    $APDN
    Financials

    Live finance-specific insights

    View All

    El Pollo Loco Holdings, Inc. to Announce Fourth Quarter and Full Year 2025 Results on Thursday, March 12, 2026

    COSTA MESA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. ("El Pollo Loco") (NASDAQ:LOCO) today announced that it will host a conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, at 4:30 PM Eastern Time. Hosting the call will be Liz Williams, Chief Executive Officer, and Ira Fils, Chief Financial Officer. A press release with fourth quarter and full year 2025 financial results will be issued that same day, shortly after the market close. The conference call can be accessed live over the phone by dialing 201-493-6780. A replay will be available after the call and can be accessed by dialing 412-317-6671; the

    2/25/26 9:00:00 AM ET
    $LOCO
    Restaurants
    Consumer Discretionary

    Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

    MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will release financial results for the fourth quarter and full year 2025 on March 10, 2026. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-343-4885 (U.S) or 1-203-518-9851 (international) and using the conference ID: N

    2/24/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Cameco Announces 2025 Results; Solid Fourth Quarter and 2025 Performance; Increasing Long-Term Uranium Market Activity Reinforces Constructive Outlook; Disciplined Supply Strategy Expected to Position Company to Unlock Value From Growing Demand

    Cameco (TSX:CCO, NYSE:CCJ) today reported its consolidated financial and operating results for the fourth quarter and year ended December 31, 2025, in accordance with International Financial Reporting Standards (IFRS). "Our fourth quarter and year-end results reflect another year of disciplined execution across our uranium, fuel services, and Westinghouse segments, demonstrating the strength of our strategy in a market that continues to evolve in support of long‑term value creation," said Tim Gitzel, Cameco's CEO. "We delivered solid performance with strong contributions from our core assets and improved financial results tied to our disciplined long-term supply strategy in a constructive

    2/13/26 6:32:00 AM ET
    $CCJ
    Other Metals and Minerals
    Basic Materials

    $ADMP
    $AGFY
    $AHG
    $APDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13D/A filed by Global Blue Group Holding AG

    SC 13D/A - Global Blue Group Holding AG (0001799983) (Subject)

    12/5/24 6:24:01 AM ET
    $GB
    EDP Services
    Technology

    SEC Form SC 13D filed by Global Blue Group Holding AG

    SC 13D - Global Blue Group Holding AG (0001799983) (Subject)

    12/5/24 6:23:14 AM ET
    $GB
    EDP Services
    Technology